John Mandrola

With more reports of mRNA COVID-19 vaccine myocarditis, parents and young adults should be allowed to weigh the vaccine decision with their clinicians without being tarred as antivaxxers.

A potential breakthrough in HFpEF, loop monitoring, a novel ablation strategy, and the saddest trial are highlighted by John Mandrola, MD, in his preview of the 2021 European Society of Cardiology sessions.

A potential breakthrough in HFpEF, loop monitoring, a novel ablation strategy, and the saddest trial are highlighted by John Mandrola, MD, in his preview of the 2021 European Society of Cardiology sessions.

The modest effects compel clinicians to be selective in the use of this costly drug, but there will be subgroups of patients who may benefit more, says John Mandrola, MD.

Obesity drugs had a good year, the SGLT2 inhibitors stalled, and Entresto looks less impressive -- these are some of the takes from John Mandrola, MD, in his annual review of cardiology research.

Dr John Mandrola gives some insight on his choices for important trials to look for at this weekend’s European Society of Cardiology Congress in Barcelona

The cardiac arrest of Buffalo Bills defensive back Damar Hamlin has led to speculation about commotio cordis and more, but one electrophysiologist sees an opportunity for education on CPR and AEDs.